How to Better Establish Clinical Utility for Tests in Personalized Medicine

Gary Palmer, MD

Video Categories: Personalized Medicine

Dr. Gary Palmer discusses the different profile of tumors and how to make findings as general as possible to better treat the patient.
October 8, 2016

Exploring the Uses of Fulvestrant

Dr Sibylle Loibl explains how fulvestrant (with or without palbociclib) fits in the treatment paradigm for patients with HR+/ HER2-negative metastatic breast cancer.

July 17, 2018

HR+/HER2- Metastatic Breast Cancer: Common Presenting Symptoms

Hope Rugo, MD, discusses common presenting symptoms of HR+/HER2- metastatic breast cancer, citing bone metastasis as the most prevalent.